{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:23:42Z","timestamp":1782865422379,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pr\u00f3-Reitoria de Pesquisa da UFMG"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.exppara.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T17:46:11Z","timestamp":1441647971000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi"],"prefix":"10.1016","volume":"159","author":[{"given":"Pulch\u00e9ria Maria Silva","family":"Higyno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Fagundes","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Barcelos de","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario Elias","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Lucas","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiane de Oliveira Pinto Coelho","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo Santana","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Aparecida de Lima","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Alves da Silva","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.exppara.2015.09.004_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.imbio.2007.05.006","article-title":"Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production","volume":"212","author":"Allam","year":"2007","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.exppara.2015.09.004_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/MCB.01282-09","article-title":"Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple","volume":"30","author":"Anderson","year":"2010","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.exppara.2015.09.004_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imm.12022","article-title":"Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection","volume":"138","author":"Borges","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.exppara.2015.09.004_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2006.12.017","article-title":"A\u00a0randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy","volume":"153","author":"Botoni","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.exppara.2015.09.004_bib4","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.exppara.2015.09.004_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00436-008-0992-6","article-title":"Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions","volume":"103","author":"Caldas","year":"2008","journal-title":"Parasitol. Res."},{"issue":"21","key":"10.1016\/j.exppara.2015.09.004_bib6","doi-asserted-by":"crossref","first-page":"14583","DOI":"10.1074\/jbc.M114.560573","article-title":"Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens","volume":"289","author":"Campos-Salinas","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exppara.2015.09.004_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2249.2010.04270.x","article-title":"Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells","volume":"163","author":"Coelho Dos Santos","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.exppara.2015.09.004_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.humimm.2013.06.028","article-title":"Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy","volume":"74","author":"Corr\u00eaa","year":"2013","journal-title":"Hum. Immunol."},{"issue":"Suppl.\u00a0I","key":"10.1016\/j.exppara.2015.09.004_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000900032","article-title":"Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy","volume":"104","author":"Cunha-Neto","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2015.09.004_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0960-5428(96)00002-2","article-title":"VIP modulation of immune cell functions","volume":"6","author":"De La Fuente","year":"1996","journal-title":"Adv. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.exppara.2015.09.004_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cdd.2008.161","article-title":"Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death","volume":"16","author":"Delgado","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.exppara.2015.09.004_bib12","first-page":"4","article-title":"Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions","volume":"3","author":"Delgado","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.exppara.2015.09.004_bib13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.162.3.1707","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in\u00a0vitro and in\u00a0vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.exppara.2015.09.004_bib14","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kB and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1996","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.exppara.2015.09.004_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pim.12107","article-title":"Immunoregulatory networks in human Chagas disease","volume":"36","author":"Dutra","year":"2014","journal-title":"Parasite Immunol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.exppara.2015.09.004_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1590\/S0074-02762009000900027","article-title":"Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease","volume":"104","author":"Dutra","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2015.09.004_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2008.05.014","article-title":"Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites","volume":"200","author":"El Karim","year":"2008","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.exppara.2015.09.004_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1189\/jlb.1004564","article-title":"Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP","volume":"78","author":"Gomariz","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.exppara.2015.09.004_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1196\/annals.1317.032","article-title":"An agent with license to kill infective parasites","volume":"1070","author":"Gonzalez-Rey","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exppara.2015.09.004_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4236\/ijcm.2011.24084","article-title":"Vasoactive intestinal peptide (VIP) and VIP receptors: elucidation of structure and function for therapeutic applications","volume":"2","author":"Igarashi","year":"2011","journal-title":"IJCM"},{"issue":"Suppl.\u00a0I","key":"10.1016\/j.exppara.2015.09.004_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1590\/S0074-02762009000900029","article-title":"Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokines receptors \u2013 how to make a dream come true","volume":"104","author":"Lannes-Vieira","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2015.09.004_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","article-title":"Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection","volume":"201","author":"Martin","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exppara.2015.09.004_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-3024.2009.01179.x","article-title":"Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease","volume":"32","author":"Paula-Costa","year":"2010","journal-title":"Parasite Immunol."},{"issue":"9","key":"10.1016\/j.exppara.2015.09.004_bib24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.peptides.2007.04.008","article-title":"Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders","volume":"28","author":"Pozo","year":"2007","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.exppara.2015.09.004_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","article-title":"Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice","volume":"171","author":"Reifenberg","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exppara.2015.09.004_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","article-title":"Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes","volume":"48","author":"Reis","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.exppara.2015.09.004_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2009.03956.x","article-title":"Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease","volume":"157","author":"Smalley","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.exppara.2015.09.004_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/B978-0-12-385895-5.00008-6","article-title":"Inflammation and Chagas disease: some mechanisms and relevance","volume":"76","author":"Talvani","year":"2011","journal-title":"Adv. Parasitol."},{"issue":"8","key":"10.1016\/j.exppara.2015.09.004_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1286-4579(00)00388-9","article-title":"Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi","volume":"2","author":"Talvani","year":"2000","journal-title":"Microbes Infect."},{"issue":"8","key":"10.1016\/j.exppara.2015.09.004_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1253\/circj.72.1303","article-title":"Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis","volume":"72","author":"Terasaki","year":"2008","journal-title":"Circ. J."},{"key":"10.1016\/j.exppara.2015.09.004_bib31","first-page":"519","article-title":"Chagas' disease (American trypanosomiasis) fact sheet (revised in August 2012)","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415300394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415300394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T21:08:31Z","timestamp":1691960911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489415300394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"alternative-id":["S0014489415300394"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2015.09.004","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}